Aerobic respiration requires the mitochondria of the cell and occurs over three distinct stages; glycolysis, the Krebs cycle and the electron transport chain. The rate of aerobic respiration is ...

This discovery potentially opens up new avenues for cancer treatments that target cellular metabolism ... where cancer cells undergo glycolysis instead of oxygen respiration—even in oxygen ...

Cuproplasia is a kind of cell proliferation mediated by the co-regulatory ... In fact, under normal circumstances, tumor cells produce energy through glycolysis, while mitochondrial respiration is ...

RNA-seq and MS analyses indicated that L-arginine switched glycolysis to oxidative phosphorylation ... and 10 mM L-arginine, mitochondrial respiration (Seahorse XF Cell Mito Stress Test) successively ...

Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

Jan 12 (Reuters) - Drug maker Johnson & Johnson (JNJ.N), opens new tab is exploring a bid to acquire Intra-Cellular Therapies (ITCI.O), opens new tab, a biopharmaceutical company, Bloomberg News ...

Johnson & Johnson said Monday it would buy Intra-Cellular Therapies in a deal worth $14.6 billion, another sign of large drugmakers’ reentry into neuroscience and a sizable purchase that will ...

J&J has offered to buy each share of Intra-Cellular for $132, representing a 39% premium to the stock's closing price on Friday. Shares of Intra-Cellular rose 34% to $128 in afternoon trading ...

(Reuters) - Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest deal in more than two years, boosting its presence in the ...